GAIN THERAPEUTICS, INC (GANX) Free cash flow 2021–2025
GAIN THERAPEUTICS, INC (GANX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$18.5MFY2025 · since FY2021: -$12.4M → -$18.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$18.5M | +2.1% |
| FY2024 | -$18.9M | +0.5% |
| FY2023 | -$19.0M | -28.4% |
| FY2022 | -$14.8M | -19.4% |
| FY2021 | -$12.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice